<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-142774" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Viscoelastics</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaur</surname>
            <given-names>Kirandeep</given-names>
          </name>
          <aff>Aravind Eye Hospital, Pondicherry</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gurnani</surname>
            <given-names>Bharat</given-names>
          </name>
          <aff>Gomabai Netralaya and Research Centre</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kirandeep Kaur declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bharat Gurnani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-142774.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Viscoelastic are substances with dual properties having a fluid's viscosity and elasticity of a gel or a solid. Viscoelastics have revolutionized modern-day cataract surgery because of their viscous, elastic, and pseudo-plastic properties. They are also called ophthalmic viscosurgical devices (OVD), introduced by the International Standards Organization (ISO). Sodium hyaluronate was the first viscoelastic introduced in 1972 as a substitute for aqueous and vitreous humor, and these compounds are an essential component of ocular surgery. This activity reviews the indications, contraindications, anatomical source, classification, properties, complications, and clinical significance of viscoelastics.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the indications of viscoelastics.</p></list-item><list-item><p>Review the classification of viscoelastics.</p></list-item><list-item><p>Summarize the complications associated with viscoelastic use.</p></list-item><list-item><p>Outline and explain the clinical significance of viscoelastics.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=142774&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=142774">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-142774.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Viscoelastics are also known as ophthalmic viscosurgical devices.<xref ref-type="bibr" rid="article-142774.r1">[1]</xref> They are solutions with dual properties.<xref ref-type="bibr" rid="article-142774.r2">[2]</xref> They have viscous properties of a fluid and elastic properties of a gel or a solid. They have also been described to have viscous, elastic, and pseudoplastic properties.<xref ref-type="bibr" rid="article-142774.r3">[3]</xref></p>
        <p>Viscoelastics were first introduced in 1972 to aid in ophthalmic surgery as a replacement for aqueous and vitreous.&#x000a0;Sodium hyaluronate was the first viscoelastic introduced in 1972 and was patented by Swedish Pharmacia as Healon in 1980. The term viscosurgery was introduced by Dr. Endre A Balazs 30 years back, which denotes the procedures and manipulations performed using OVDs.<xref ref-type="bibr" rid="article-142774.r4">[4]</xref></p>
        <p>Viscoelastics are commonly used in cataract surgery to assist in capsulotomy and nucleus manipulation, corneal surgeries, glaucoma surgeries, open globe repairs, retinal surgery, pediatric and strabismus surgeries. Viscoelastics can be classified based on the source and rheological properties. The various complications associated with viscoelastics are secondary glaucoma, capsular block syndrome, capsular bag distension syndrome, pseudo anterior uveitis, IOL crystallization, and calcific band keratopathy.<xref ref-type="bibr" rid="article-142774.r5">[5]</xref></p>
      </sec>
      <sec id="article-142774.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>
<bold>Ideal OVD Properties</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Optically transparent and clear</p>
          </list-item>
          <list-item>
            <p>Non-toxic</p>
          </list-item>
          <list-item>
            <p>Non-inflammable and nonpyrogenic</p>
          </list-item>
          <list-item>
            <p>Not insight any inflammatory reaction</p>
          </list-item>
          <list-item>
            <p>Non-immunogenic</p>
          </list-item>
          <list-item>
            <p>Sterile and free from any reaction inside the human eye</p>
          </list-item>
          <list-item>
            <p>Should have good viscosity to prevent the collapse of AC at rest</p>
          </list-item>
          <list-item>
            <p>Should have an ability of retention under pressure, should be highly cohesive with high viscosity</p>
          </list-item>
          <list-item>
            <p>Should have good endothelium protective properties with minimal surface activity</p>
          </list-item>
          <list-item>
            <p>Should be easy to remove from the anterior chamber</p>
          </list-item>
          <list-item>
            <p>Should be cost-effective</p>
          </list-item>
          <list-item>
            <p>Should not obstruct aqueous outflow</p>
          </list-item>
          <list-item>
            <p>Should be elastic and have shock-absorbing properties</p>
          </list-item>
          <list-item>
            <p>Should be liquid enough so that it can be injected through a small-bore cannula<xref ref-type="bibr" rid="article-142774.r6">[6]</xref></p>
          </list-item>
        </list>
        <p><bold>Stabilizing defect&#x000a0;</bold>- High viscosity at a low shear rate help to maintain space and protect tissues</p>
        <p><bold>Mobilizing effect - </bold>Moderate viscosity at medium shear rate help in the movement of instruments.</p>
        <p>Low viscosity at high shear rates helps in the easy introduction into the eye through a small-bore cannula<xref ref-type="bibr" rid="article-142774.r7">[7]</xref></p>
        <p>
<bold>Physical and Rheological Properties of Viscoelastics</bold>
</p>
        <p>
<bold>Viscosity</bold>
</p>
        <p>It refers to the solution's resistance to flow. Higher the viscosity of a viscoelastic, better is its ability to maintain a uniform shape and difficulty in displacement. Viscosity is dependent on concentration, molecular weight, shear rate, and temperature. An ideal viscoelastic should maintain space for accurate instrumentation during the surgery. It is measured in centipoise and millipascals.<xref ref-type="bibr" rid="article-142774.r8">[8]</xref></p>
        <p>
<bold>Pseudo-plasticity</bold>
</p>
        <p>This is a unique property of viscoelastic. It refers to the ability of viscoelastic to change from gel to a liquid under pressure. It is also defined as the ability to pass from a state of high viscosity at rest to low viscosity at high shear rates. Sodium hyaluronate has greater pseudo-plasticity than hydroxypropyl methylcellulose (HPMC) and chondroitin sulfate. Sodium hyaluronate can be injected through a 30G needle, while HPMC will require a 25G needle.<xref ref-type="bibr" rid="article-142774.r3">[3]</xref></p>
        <p>
<bold>Viscoelasticity</bold>
</p>
        <p>It is the property of a substance to retain its original form after it has been stretched and deformed. It increases with high molecular weight and increases in the chain length of the molecules. This viscoelastic property helps absorb traumatic maneuvers like shocks during phacoemulsification and the unfolding of IOL during implantation. Sodium hyaluronate has more viscoelasticity than HPMC or chondroitin sulfate.<xref ref-type="bibr" rid="article-142774.r5">[5]</xref></p>
        <p>
<bold>Rigidity</bold>
</p>
        <p>This is also known as complex viscosity. It means the resistance felt while maneuvering the object through a viscoelastic. It is defined as the square root of the sum of squares of viscosity and elasticity.</p>
        <p>
<bold>Surface Tension</bold>
</p>
        <p>It is a property by which a viscoelastic coat the surface. This property is also governed by the contact angle formed by a drop of viscoelastic on a flat surface. Lower surface tension and low contact angle have better coating ability. The surface tension of sodium hyaluronate is less; hence it has a better coating ability.<xref ref-type="bibr" rid="article-142774.r9">[9]</xref></p>
        <p>
<bold>Viscoadaptability</bold>
</p>
        <p>This is a viscoelastic property wherein it changes from a supraviscous state at a low shear rate to a fracturable (pseudo-dispersive) at a higher shear rate. Healon 5 has high viscoadaptability and has revolutionized the application of viscoelastics.</p>
        <p>
<bold>Cohesiveness </bold>
</p>
        <p>Cohesiveness is a property by which molecules of viscoelastics adhere to one another and form a clump. Higher the molecular weight, higher the surface tension, and higher the pseudo-plasticity, higher is the cohesiveness of a viscoelastic. Sodium hyaluronate is more cohesive than HPMC and is challenging to aspirate from the anterior chamber during surgery.<xref ref-type="bibr" rid="article-142774.r10">[10]</xref></p>
        <p>
<bold>Dispersiveness</bold>
</p>
        <p>Dispersive viscoelastics have less tendency to adhere to each other. Viscoelastics with low molecular weight, low surface tension, and low pseudo-plasticity are dispersive viscoelastics.</p>
        <p>
<bold>Coatability</bold>
</p>
        <p>Higher the molecular weight of a viscoelastic, the higher the coatability. More negatively charged sodium hyaluronate and chondroitin sulfate complex has a greater affinity for positively charged instruments, tissues, and implants.<xref ref-type="bibr" rid="article-142774.r11">[11]</xref></p>
        <p>
<bold>Classification of Viscoelastics</bold>
</p>
        <p>
<bold>Viscoelastics are classified based on the </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Rheological Properties</p>
          </list-item>
          <list-item>
            <p>Source<xref ref-type="bibr" rid="article-142774.r12">[12]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Classification based on Rheological Properties</bold>
</p>
        <p>
<bold>Arshinoff's classification</bold>
<xref ref-type="bibr" rid="article-142774.r13">[13]</xref>
</p>
        <table-wrap id="article-142774.table0" position="float" orientation="portrait">
          <table style="width: 1320px;">
            <tbody>
              <tr>
                <td style="width: 26px;" rowspan="1" colspan="1">
<p><bold>S. No</bold></p>
</td>
                <td style="width: 149px;" rowspan="1" colspan="1">
<p><bold>Type </bold></p>
</td>
                <td style="width: 166.031px;" rowspan="1" colspan="1">
<p><bold>Examples</bold></p>
</td>
                <td style="width: 238.969px;" rowspan="1" colspan="1">
<p><bold>Properties</bold></p>
</td>
                <td style="width: 251px;" rowspan="1" colspan="1">
<p><bold>Advantages </bold></p>
</td>
                <td style="width: 444px;" rowspan="1" colspan="1">
<p><bold>Disadvantages</bold></p>
</td>
              </tr>
              <tr>
                <td style="width: 26px;" rowspan="1" colspan="1">
<p><bold>1.</bold></p>
</td>
                <td style="width: 149px;" rowspan="1" colspan="1">
<p><bold>Cohesives (Higher viscosity)</bold></p>
<p><bold>&#x000a0;</bold></p>
</td>
                <td style="width: 166.031px;" rowspan="1" colspan="1">
<p>Hyaluronic acid&#x000a0;</p>
</td>
                <td style="width: 238.969px;" rowspan="1" colspan="1">
<p>High molecular weight,</p>
<p>High viscosity,</p>
<p>High pseudoplasticity,</p>
<p>High surface tension and</p>
<p>Less coatability</p>
</td>
                <td style="width: 251px;" rowspan="1" colspan="1">
<p>Help to create space</p>
<p>Induce and sustain pressure</p>
</td>
                <td style="width: 444px;" rowspan="1" colspan="1">
<p>Greater tendency to escape</p>
<p>Less corneal endothelial protection</p>
<p>If left in the anterior chamber can cause secondary glaucoma</p>
</td>
              </tr>
              <tr>
                <td style="width: 26px;" rowspan="1" colspan="1">
<p><bold>2</bold></p>
</td>
                <td style="width: 149px;" rowspan="1" colspan="1">
<p><bold>Dispersives (Lower viscosity)</bold></p>
<p><bold>&#x000a0;</bold></p>
</td>
                <td style="width: 166.031px;" rowspan="1" colspan="1">
<p>Hyaluronic acid</p>
<p>Chondroitin sulfate</p>
<p>Hydroxypropylmethylcellulose</p>
</td>
                <td style="width: 238.969px;" rowspan="1" colspan="1">
<p>Prolonged retention time, create partition spaces</p>
</td>
                <td style="width: 251px;" rowspan="1" colspan="1">
<p>Lesser tendency to escape from the anterior chamber, better protection of intraocular structures</p>
<p>Protect cornea in Fuchs' endothelial dystrophy patients</p>
</td>
                <td style="width: 444px;" rowspan="1" colspan="1">
<p>It is aspirated in small fragments creating an irregular viscoelastic-aqueous interface that partially obscures the view</p>
<p>Difficult to remove</p>
</td>
              </tr>
              <tr>
                <td style="width: 26px;" rowspan="1" colspan="1">
<p><bold>3</bold></p>
</td>
                <td style="width: 149px;" rowspan="1" colspan="1">
<p><bold>Viscoadaptives</bold></p>
<p><bold>&#x000a0;</bold></p>
</td>
                <td style="width: 166.031px;" rowspan="1" colspan="1">
<p>Hyaluronic acid</p>
</td>
                <td style="width: 238.969px;" rowspan="1" colspan="1">
<p>Act as cohesives under low shear stress</p>
<p>Also called pseudo-dispersive</p>
</td>
                <td style="width: 251px;" rowspan="1" colspan="1">
<p>Ultra-viscous cohesive (solids)</p>
</td>
                <td style="width: 444px;" rowspan="1" colspan="1">
<p>Under high fluid flow, they easily fracture, freeing pieces to float</p>
<p>Retained in the anterior segment similar to dispersive OVDs</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Classification According to the Source</bold>
</p>
        <table-wrap id="article-142774.table1" position="float" orientation="portrait">
          <table style="width: 1210px;">
            <tbody>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p><bold>S. No</bold></p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p><bold>Viscoelastic</bold></p>
<p><bold>content</bold></p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p><bold>Anatomical&#x000a0;</bold><bold>Source</bold></p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p><bold>Colour</bold></p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p><bold>Contact&#x000a0;</bold><bold>Angle</bold></p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p><bold>Pseudo-plasticity</bold></p>
</td>
              </tr>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p>1</p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p>1% Sodium hyaluronate</p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p>Rooster comb</p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p>Transparent</p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p>60 degrees</p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p>High</p>
</td>
              </tr>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p>2</p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p>2.3% Sodium hyaluronate</p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p>Rooster comb</p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p>Transparent</p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p>-</p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p>Very high</p>
</td>
              </tr>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p>3</p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p>1.4% Sodium hyaluronate</p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p>Rooster comb</p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p>Transparent</p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p>-</p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p>Very high</p>
</td>
              </tr>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p>4</p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p>2% Hydroxypropyl-</p>
<p>methylcellulose</p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p>Wood pulp</p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p>Transparent</p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p>-</p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p>Medium</p>
</td>
              </tr>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p>5</p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p>1.2% Sodium hyaluronate</p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p>Rooster comb</p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p>Transparent</p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p>60 degrees</p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p>High</p>
</td>
              </tr>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p>6</p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p>3% Sodium hyaluronate + 4%</p>
<p>Chondroitin sulfate</p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p>Bacterial Fermentation</p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p>Transparent</p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p>52 degrees</p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p>Medium</p>
</td>
              </tr>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p>7</p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p>3% Hydroxypropyl-</p>
<p>methylcellulose</p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p>Wood pulp</p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p>Transparent</p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p>-</p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p>Low</p>
</td>
              </tr>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p>8</p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p>3% Sodium hyaluronate</p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p>Rooster comb</p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p>Transparent</p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p>-</p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p>High</p>
</td>
              </tr>
              <tr>
                <td style="width: 77.6719px;" rowspan="1" colspan="1">
<p>9</p>
</td>
                <td style="width: 200.328px;" rowspan="1" colspan="1">
<p>Chondroitin Sulphate</p>
</td>
                <td style="width: 204px;" rowspan="1" colspan="1">
<p>Shark fin cartilage</p>
</td>
                <td style="width: 220px;" rowspan="1" colspan="1">
<p>Yellow</p>
</td>
                <td style="width: 197px;" rowspan="1" colspan="1">
<p>-</p>
</td>
                <td style="width: 248px;" rowspan="1" colspan="1">
<p>High</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-142774.s4" sec-type="Indications">
        <title>Indications</title>
        <p>
<bold>Cataract Surgery</bold>
</p>
        <p>Viscoelastics form an essential component for every step of all types of cataract surgery, whether it is phacoemulsification, manual small incision cataract surgery (MSICS), extracapsular cataract extraction (ECCE), or intracapsular cataract extraction (ICCE). Viscoelastics assist in capsulorhexis, hydrodissection, nucleus prolapse and manipulation, trenching and emulsification of nucleus, IOL implantation, and they also coat the endothelium and prevent corneal damage. The primary function of OVDs is to form the anterior chamber by replacing aqueous humor.</p>
        <p>For capsulorhexis, a viscoelastic should have high viscosity, high transparency, good capsular flap control for a spatula effect, and high molecular weight at zero shear rate and must maintain the anterior chamber. The pediatric capsule is highly elastic; hence high density viscoelastic like Healon GV is viscoelastic of choice. In the case of posterior capsular rent during irrigation and aspiration, a dispersive viscoelastic is used to plug the defect.<xref ref-type="bibr" rid="article-142774.r5">[5]</xref></p>
        <p>
<bold>Viscoelastics Required During Various Steps of Phacoemulsification</bold>
</p>
        <table-wrap id="article-142774.table2" position="float" orientation="portrait">
          <table style="width: 1247px;">
            <tbody>
              <tr>
                <td style="width: 70.0781px;" rowspan="1" colspan="1">
<p>S. No</p>
</td>
                <td style="width: 105.922px;" rowspan="1" colspan="1">
<p>Surgical step</p>
</td>
                <td style="width: 455px;" rowspan="1" colspan="1">
<p>Function of viscoelastic</p>
</td>
                <td style="width: 316px;" rowspan="1" colspan="1">
<p>Property of viscoelastic helpful</p>
</td>
                <td style="width: 123px;" rowspan="1" colspan="1">
<p>Viscoelastic used</p>
</td>
                <td style="width: 133px;" rowspan="1" colspan="1">
<p>Example</p>
</td>
              </tr>
              <tr>
                <td style="width: 70.0781px;" rowspan="1" colspan="1">
<p>1</p>
</td>
                <td style="width: 105.922px;" rowspan="1" colspan="1">
<p>Capsulorhexis</p>
</td>
                <td style="width: 455px;" rowspan="1" colspan="1">
<p>Maintain the anterior chamber</p>
</td>
                <td style="width: 316px;" rowspan="1" colspan="1">
<p>High viscosity, elasticity</p>
</td>
                <td style="width: 123px;" rowspan="1" colspan="1">
<p>Cohesive viscoelastic</p>
</td>
                <td style="width: 133px;" rowspan="1" colspan="1">
<p>1% Sodium hyaluronate</p>
</td>
              </tr>
              <tr>
                <td style="width: 70.0781px;" rowspan="1" colspan="1">
<p>2</p>
</td>
                <td style="width: 105.922px;" rowspan="1" colspan="1">
<p>Nucleus trenching</p>
</td>
                <td style="width: 455px;" rowspan="1" colspan="1">
<p>Corneal endothelial protection by coating it</p>
</td>
                <td style="width: 316px;" rowspan="1" colspan="1">
<p>High viscosity, low molecular weight, and surface tension</p>
</td>
                <td style="width: 123px;" rowspan="1" colspan="1">
<p>Dispersive viscoelastic</p>
</td>
                <td style="width: 133px;" rowspan="1" colspan="1">
<p>2% Hydroxypropyl</p>
<p>Methylcellulose</p>
<p>(HPMC)</p>
</td>
              </tr>
              <tr>
                <td style="width: 70.0781px;" rowspan="1" colspan="1">
<p>3</p>
</td>
                <td style="width: 105.922px;" rowspan="1" colspan="1">
<p>Cortex removal</p>
</td>
                <td style="width: 455px;" rowspan="1" colspan="1">
<p>Inflation of capsular bag, protection of posterior capsule</p>
</td>
                <td style="width: 316px;" rowspan="1" colspan="1">
<p>Low surface tension</p>
</td>
                <td style="width: 123px;" rowspan="1" colspan="1">
<p>Dispersive viscoelastic</p>
</td>
                <td style="width: 133px;" rowspan="1" colspan="1">
<p>2% Hydroxypropyl</p>
<p>Methylcellulose</p>
<p>(HPMC)</p>
</td>
              </tr>
              <tr>
                <td style="width: 70.0781px;" rowspan="1" colspan="1">
<p>4</p>
</td>
                <td style="width: 105.922px;" rowspan="1" colspan="1">
<p>IOL implantation</p>
</td>
                <td style="width: 455px;" rowspan="1" colspan="1">
<p>Inflation of capsular bag, protection of posterior capsule, maintenance of anterior chamber</p>
</td>
                <td style="width: 316px;" rowspan="1" colspan="1">
<p>High viscosity, elasticity</p>
</td>
                <td style="width: 123px;" rowspan="1" colspan="1">
<p>Cohesive viscoelastic</p>
</td>
                <td style="width: 133px;" rowspan="1" colspan="1">
<p>1% Sodium hyaluronate</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Glaucoma Surgeries</bold>
</p>
        <p>In trabeculectomy, hyaluronic acid is the viscoelastic of choice. It helps to prevent endothelial trauma maintain the anterior chamber depth. Some surgeons leave viscoelastic in the anterior chamber to prevent postoperative hypotony and retino-choroidal folds. Viscoelastic can also be injected subconjunctivally for bleb formation.</p>
        <p>In viscocanalostomy surgery, viscoelastic is used to open the Schlemm canal. Hyaluronic acid containing viscoelastics is used for viscocanalostomy as they have high pseudo-plasticity and high viscosity. Due to these properties, the viscoelastic can be injected into the Schlemm canal through a small needle, and they help maintain the space.<xref ref-type="bibr" rid="article-142774.r14">[14]</xref></p>
        <p>
<bold>Corneal Surgeries</bold>
</p>
        <p>In penetrating keratoplasty, the viscoelastic helps maintain the anterior chamber before trephination, provides good support for perfect trephination, helps in the protection of intraocular structures, tamponade the vitreous, and coat the corneal donor button while suturing to prevent endothelial damage. Viscoelastics also play a significant role in deep anterior lamellar keratoplasty (DALK) for layer by layer removal of the host cornea and for exposing the Descemet membrane (DM) during surgery. In Descemet stripping, endothelial keratoplasty (DSEK) and Descemet membrane endothelial keratoplasty (DMEK) viscoelastic help perform DM scoring and any anterior chamber maneuvers. In femtosecond laser application of cornea, viscoelastics help to protect the corneal endothelium.</p>
        <p>
<bold>Viscoanaesthesia</bold>
</p>
        <p>Viscoelastic can be mixed with lidocaine, and the mixture is used for intracameral anesthesia. This treatment modality is labeled as viscoanaethesia. Viscoelastic helps to prolong the effect of lidocaine.<xref ref-type="bibr" rid="article-142774.r15">[15]</xref></p>
        <p>
<bold>Viscomydriasis</bold>
</p>
        <p>Viscoelastic specially cohesives help to dilate the pupil during the surgery. In small pupil cases, it helps in viscomydriasis.<xref ref-type="bibr" rid="article-142774.r16">[16]</xref></p>
        <p>
<bold>Intraoperative Floppy Iris Syndrome (IFIS)</bold>
</p>
        <p>Intraoperative Floppy Iris Syndrome (IFIS) is a known complication in patients treated for prostatic hyperplasia with alpha-adrenergic blockers. Viscoadaptive viscoelastics are helpful in such a scenario to dilate and stabilize the pupil. This also helps to prevent iris prolapse.<xref ref-type="bibr" rid="article-142774.r17">[17]</xref></p>
        <p>
<bold>Retinal Surgery</bold>
</p>
        <p>The membranous adhesions during retinal surgery can be safely separated and excised with the help of viscoelastics. It also helps to release the traction. Sodium hyaluronate is one of the most commonly used viscoelastic during retinal surgeries.<xref ref-type="bibr" rid="article-142774.r18">[18]</xref></p>
        <p>
<bold>Orbit and Oculoplasty Surgery</bold>
</p>
        <p><bold>Congenital Nasolacrimal Duct Obstruction (CNLDO)- </bold>Viscoelastic helps pass the probe through the NLD and keeps the NLD patent.<xref ref-type="bibr" rid="article-142774.r19">[19]</xref></p>
        <p><bold>Ptosis Surgery&#x000a0;</bold>- It helps to avoid friction with fascia lata.</p>
        <p><bold>Dacryocystorhinostomy (DCR) - </bold>In DCR surgery, it helps in to separate the adhesions and identify the lacrimal sac</p>
        <p><bold>Lacrimal Canaliculus tear - </bold>Viscoelastics help to identify the cut ends.</p>
        <p>
<bold>Pediatric Ophthalmology and Strabismus Surgery</bold>
</p>
        <p>In pediatric cataract, viscoelastic help in all the routine steps of cataract surgery. In strabismus, surgery helps in suture adjustment with less force, helps to coat the muscle, and decreases scar formation in the muscular tissues.<xref ref-type="bibr" rid="article-142774.r20">[20]</xref></p>
      </sec>
      <sec id="article-142774.s5" sec-type="Preparation">
        <title>Preparation</title>
        <p>
<bold>Sodium Hyaluronate</bold>
</p>
        <p>It is a salt derivative of hyaluronic acid and is present in the connective tissue of bacteria and humans. In homo sapiens, it is found in skin, synovial fluid, and vitreous humor. Sodium hyaluronate was first extracted from the vitreous humor of cows, and Mayer and Palmer named it because it is derived from hyaloids and contains uronic acid. The commercially available formulation is extracted from rooster coombs or streptococcal bacterial culture. Sodium hyaluronate is a long-chain mucopolysaccharide chain with a molecular weight of 2.5&#x000a0;to 4 million Daltons. The viscosity ranges from 100000&#x000a0;to 30000 centipoise with a half-life of 1 day in aqueous and three days in vitreous. The characteristic properties of sodium hyaluronate are sterile, noninflammatory, non-toxic, nonantigenic, and nonpyrogenic.<xref ref-type="bibr" rid="article-142774.r21">[21]</xref></p>
        <p>
<bold>Chondroitin Sulphate</bold>
</p>
        <p>The physical and chemical characteristics of chondroitin sulfate are similar to sodium hyaluronate. The structure of chondroitin sulfate differs by a sulfated group and double negative charge for every subunit. Commercially available choroid tin sulfate is derived from shark cartilage. It is found in the cornea as one of the three major mucopolysaccharides.<xref ref-type="bibr" rid="article-142774.r22">[22]</xref></p>
        <p>
<bold>Various Preparations of Chondroitin Sulphate</bold>
</p>
        <p>
<bold>Isolated Chondroitin Sulphate (20%)</bold>
</p>
        <p>It is a low viscosity preparation and not a space maintainer; instead helps in surface protection. The viscosity can be increased as 50% solution, but this formulation can cause damage to the corneal endothelium.</p>
        <p>
<bold>Chondroitin Sulphate and Sodium Hyaluronate</bold>
</p>
        <p>It is more viscous and has a better coating ability.<xref ref-type="bibr" rid="article-142774.r23">[23]</xref></p>
        <p>
<bold>Hydroxypropyl Methylcellulose (HPMC)</bold>
</p>
        <p>HPMC is cellulose-derived and extracted from plant fibers like cotton and wood. It is not found in animal tissues. The viscosity of HPMC is 3000&#x000a0;to 4000 centipoise. It is less viscous and lacks the properties of a complete viscoelastic. The molecular weight is 86000; pH is 7.2, and osmolarity of 285 milliosmoles. It is sterilized by autoclaving and has a shelf life of 2 years at room temperature.<xref ref-type="bibr" rid="article-142774.r24">[24]</xref></p>
      </sec>
      <sec id="article-142774.s6" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Techniques of Viscoelastic Removal</bold>
</p>
        <p>
<bold>Rock and Roll Technique</bold>
</p>
        <p>In this technique, the irrigation and aspiration (I/A) tips are positioned away from the posterior capsule. The optic is pushed and angled to one side, and viscoelastic is removed from under the optic. A similar maneuver is performed on the contralateral side to remove the remaining viscoelastic.<xref ref-type="bibr" rid="article-142774.r25">[25]</xref></p>
        <p>
<bold>Compartment Technique Using Bimanual Irrigation and Aspiration</bold>
</p>
        <p>&#x000a0;The irrigation and aspiration tip can be moved back and forth to assist the removal of viscoelastic compartments.<xref ref-type="bibr" rid="article-142774.r26">[26]</xref></p>
        <p>
<bold>Tapping Technique</bold>
</p>
        <p>The IOL surface is tapped with the I/A tip to dislodge the viscoelastic under the surface of IOL and then can be removed by simple I/A.</p>
        <p>
<bold>Spinning Technique</bold>
</p>
        <p>After IOL implantation, the IOL can be dialed 360 degrees to remove the remaining residual viscoelastic at the equator.</p>
      </sec>
      <sec id="article-142774.s7" sec-type="Complications">
        <title>Complications</title>
        <p>The various complications associated with viscoelastics are</p>
        <p>
<bold>Secondary Glaucoma</bold>
</p>
        <p>If the viscoelastic is not thoroughly washed intraoperatively from the anterior chamber and capsular bag, it will result in a post-operative IOP spike, usually within 6 to 24 hours. The IOP increases because the trabecular meshwork is clogged, and there is mechanical resistance with large particles of the OVD. In most cases, it resolves spontaneously after 72 hours, but if the IOP rise is persistent, it should be managed with antiglaucoma medications.<xref ref-type="bibr" rid="article-142774.r27">[27]</xref></p>
        <p>
<bold>Capsular Block Syndrome</bold>
</p>
        <p>Capsular block syndrome (CBS) or capsular block distention syndrome has been reported after viscoelastic use. It refers to the collection of fluid or viscoelastic in the capsular bag behind the nucleus or IOL. The nucleus or IOL is pushed forward, blocking the anterior capsular opening. CBS has been classified as</p>
        <p><bold>Intraoperative&#x000a0;</bold>- Due to collection of balanced salt solution in the capsular bag during hydrodissection.</p>
        <p><bold>Early post-operative&#x000a0;</bold>-&#x000a0; Due to the viscoelastic accumulation in the capsular bag at the end of surgery.</p>
        <p><bold>Late post-operative&#x000a0;</bold>- High-density viscoelastic accumulation in the capsular bag like hyaluronic acid in the capsular bag.<xref ref-type="bibr" rid="article-142774.r28">[28]</xref></p>
        <p>
<bold>Pseudo-Anterior Uveitis</bold>
</p>
        <p>Due to high viscous property and negative electrostatic charge, the red blood and inflammatory cells may clump and remain suspended in the anterior chamber. This resolves spontaneously within three days. Sometimes the hyphema or the blood clot may get trapped within the vitreous phase and OVD in the anterior chamber mimicking vitreous hemorrhage.<xref ref-type="bibr" rid="article-142774.r29">[29]</xref></p>
        <p>
<bold>Postoperative Uveitis and Hypopyon</bold>
</p>
        <p>This complication has also been reported after OVD instillation.<xref ref-type="bibr" rid="article-142774.r30">[30]</xref></p>
        <p>
<bold>Corneal Edema and Decompensation</bold>
</p>
        <p>This is also have been reported after OVD use.<xref ref-type="bibr" rid="article-142774.r31">[31]</xref>&#x000a0;</p>
        <p>
<bold>IOL Surface Crystallization</bold>
</p>
        <p>It occurs due to residues of viscoelastic solution over the IOL surface. The deposits take the pattern of a fern or an amorphous deposit. The IOL calcification mandates an explantation or an exchange.<xref ref-type="bibr" rid="article-142774.r32">[32]</xref></p>
        <p>
<bold>Calcific Band Keratopathy</bold>
</p>
        <p>This has been reported with chondroitin sulfate-containing OVD.<xref ref-type="bibr" rid="article-142774.r33">[33]</xref></p>
        <p>
<bold>Hypersensitivity</bold>
</p>
        <p>A small risk of hypersensitivity exists with OVD as sodium hyaluronate is extracted from rooster coombs or streptococcal bacterial culture containing proteins.<xref ref-type="bibr" rid="article-142774.r34">[34]</xref></p>
      </sec>
      <sec id="article-142774.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Techniques Helpful During Surgery</bold>
</p>
        <p>
<bold>Soft Shell Technique</bold>
</p>
        <p>In the soft shell technique, a dispersive viscoelastic is injected in the anterior chamber forming a small clump on the anterior lens surface. Next, a cohesive viscoelastic is injected below the dispersive on the posterior surface, which pushes the dispersive upwards on the back surface of the cornea, thus protecting the endothelial cells. This technique is helpful during phacoemulsification and irrigation aspiration as it protects the corneal endothelium from trauma due to ultrasound energy and excessive fluid turbulence irrigation. The softshell technique is beneficial in Fuch's endothelial dystrophy, congenital hereditary endothelial dystrophy, extreme crocodile shagreen cases, and denser cataracts (Brown and Intumescent cataract).<xref ref-type="bibr" rid="article-142774.r35">[35]</xref></p>
        <p>
<bold>Ultimate Soft- Shell Technique</bold>
</p>
        <p>In this technique, a viscoadaptive viscoelastic is first injected in the anterior chamber, and then balance salt solution (BSS) is filled beneath the viscoadaptive viscoelastic. The ultimate softshell technique was introduced to cut down the cost due to the soft shell technique since it employed two different viscoelastics. The viscoelastic in this technique plug the incisional wound, while BSS over the anterior lens surface helps to reduce the resistance while performing surgical maneuvers.<xref ref-type="bibr" rid="article-142774.r36">[36]</xref></p>
        <p>
<bold>Tri- Soft Shell Technique</bold>
</p>
        <p>This technique first injects a dispersive viscoelastic in the anterior chamber above the lens surface. Then a viscoadaptive viscoelastic is injected below the dispersive to float the dispersive to coat and protect the endothelium.<xref ref-type="bibr" rid="article-142774.r37">[37]</xref></p>
      </sec>
      <sec id="article-142774.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Viscoelastic are substances with dual properties having a viscosity of a fluid and elasticity of a gel or a solid. They are commonly employed in all kinds of ophthalmic surgical interventions. The nurses, mid-level ophthalmic personnel, pharmacist, allied health, and OT store staff have a crucial role in arranging the viscoelastics during the surgical intervention.</p>
        <p>The ophthalmic surgeon should make judicious and timely use of viscoelastics during surgical intervention with no trauma to the ocular structures. It is the responsibility of the operating surgeon to ensure that the viscoelastic is washed thoroughly from the eye at the end of the surgical procedure. In case of any ocular complication of viscoelastic the surgeon and the paramedical staff also has to play an essential role in prompt and meticulous treatment.<xref ref-type="bibr" rid="article-142774.r6">[6]</xref></p>
      </sec>
      <sec id="article-142774.s10" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>The nurses also play an essential role in ensuring the availability and maintaining the sterility of commonly employed viscoelastics. In addition, the allied health and interprofessional team play a key role in arranging the required viscoelastics and ensuring sterility.</p>
      </sec>
      <sec id="article-142774.s11" sec-type="Nursing, Allied Health, and Interprofessional Team Monitoring">
        <title>Nursing, Allied Health, and Interprofessional Team Monitoring</title>
        <p>The nursing, allied health, and interprofessional team also play a crucial role in monitoring the patient outcome and ensuring the availability of viscoelastics.</p>
      </sec>
      <sec id="article-142774.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=142774&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=142774">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/142774/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=142774">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-142774.s13">
        <title>References</title>
        <ref id="article-142774.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Higashide</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Use of viscoelastic substance in ophthalmic surgery - focus on sodium hyaluronate.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-30</page-range>
            <pub-id pub-id-type="pmid">19668386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silver</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>LiBrizzi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Benedetto</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Use of viscoelastic solutions in ophthalmology: a review of physical properties and long-term effects.</article-title>
            <source>J Long Term Eff Med Implants</source>
            <year>1992</year>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-66</page-range>
            <pub-id pub-id-type="pmid">10149916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borkenstein</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Borkenstein</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Malyugin</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic Viscosurgical Devices (OVDs) in Challenging Cases: a Review.</article-title>
            <source>Ophthalmol Ther</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>831</fpage>
            <page-range>831-843</page-range>
            <pub-id pub-id-type="pmid">34617249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holzer</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Tetz</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Auffarth</surname>
                <given-names>GU</given-names>
              </name>
              <name>
                <surname>Welt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>V&#x000f6;lcker</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-8</page-range>
            <pub-id pub-id-type="pmid">11226784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hessemer</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>[Viscoelastic substances in cataract surgery. Principles and current overview].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>1996</year>
            <season>Aug-Sep</season>
            <volume>209</volume>
            <issue>2-3</issue>
            <fpage>55</fpage>
            <page-range>55-61</page-range>
            <pub-id pub-id-type="pmid">8992084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liesegang</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Viscoelastic substances in ophthalmology.</article-title>
            <source>Surv Ophthalmol</source>
            <year>1990</year>
            <season>Jan-Feb</season>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>268</fpage>
            <page-range>268-93</page-range>
            <pub-id pub-id-type="pmid">2111587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arshinoff</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>New terminology: ophthalmic viscosurgical devices.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2000</year>
            <month>May</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>627</fpage>
            <page-range>627-8</page-range>
            <pub-id pub-id-type="pmid">10831880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cowman</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Raghavan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stecco</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Viscoelastic Properties of Hyaluronan in Physiological Conditions.</article-title>
            <source>F1000Res</source>
            <year>2015</year>
            <volume>4</volume>
            <fpage>622</fpage>
            <pub-id pub-id-type="pmid">26594344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fathi-Azarbayjani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jouyban</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Surface tension in human pathophysiology and its application as a medical diagnostic tool.</article-title>
            <source>Bioimpacts</source>
            <year>2015</year>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-44</page-range>
            <pub-id pub-id-type="pmid">25901295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dick</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Krummenauer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Augustin</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Pakula</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Healon5 viscoadaptive formulation: Comparison to Healon and Healon GV.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>320</fpage>
            <page-range>320-6</page-range>
            <pub-id pub-id-type="pmid">11226801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Heo</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Protective effects of dispersive viscoelastics on corneal endothelial damage in a toxic anterior segment syndrome animal model.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2012</year>
            <month>Sep</month>
            <day>19</day>
            <volume>53</volume>
            <issue>10</issue>
            <fpage>6164</fpage>
            <page-range>6164-70</page-range>
            <pub-id pub-id-type="pmid">22899758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dick</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schwenn</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>[Classification of visco-elastic substances for ophthalmologic surgery].</article-title>
            <source>Ophthalmologe</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>193</fpage>
            <page-range>193-211</page-range>
            <pub-id pub-id-type="pmid">10234968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arshinoff</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jafari</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>New classification of ophthalmic viscosurgical devices--2005.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>2167</fpage>
            <page-range>2167-71</page-range>
            <pub-id pub-id-type="pmid">16412934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurtz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leibovitch</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Combined perfluoropropane gas and viscoelastic material injection for anterior chamber reformation following trabeculectomy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>86</volume>
            <issue>11</issue>
            <fpage>1225</fpage>
            <page-range>1225-7</page-range>
            <pub-id pub-id-type="pmid">12386073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carino</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Slomovic</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Marcovich</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Topical tetracaine versus topical tetracaine plus intracameral lidocaine for cataract surgery.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>1998</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>12</issue>
            <fpage>1602</fpage>
            <page-range>1602-8</page-range>
            <pub-id pub-id-type="pmid">9850898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jhanji</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vajpayee</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Management of Intraoperative Miosis during Pediatric Cataract Surgery using Healon 5.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-7</page-range>
            <pub-id pub-id-type="pmid">21572735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haridas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Syrimi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Al-Ahmar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hingorani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>251</volume>
            <issue>6</issue>
            <fpage>1541</fpage>
            <page-range>1541-5</page-range>
            <pub-id pub-id-type="pmid">23420297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crafoord</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stenkula</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Healon GV in posterior segment surgery.</article-title>
            <source>Acta Ophthalmol (Copenh)</source>
            <year>1993</year>
            <month>Aug</month>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>560</fpage>
            <page-range>560-1</page-range>
            <pub-id pub-id-type="pmid">8249593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vagge</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferro Desideri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nucci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Serafino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giannaccare</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lembo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Traverso</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review.</article-title>
            <source>Diseases</source>
            <year>2018</year>
            <month>Oct</month>
            <day>22</day>
            <volume>6</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">30360371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Faraoni</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Viscoelastic testing in pediatric patients.</article-title>
            <source>Transfusion</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>60 Suppl 6</volume>
            <fpage>S75</fpage>
            <page-range>S75-S85</page-range>
            <pub-id pub-id-type="pmid">33089938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Althomali</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Viscoelastic substance in prefilled syringe as an etiology of Toxic Anterior Segment Syndrome.</article-title>
            <source>Cutan Ocul Toxicol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-41</page-range>
            <pub-id pub-id-type="pmid">26362248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Volpi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Chondroitin Sulfate Safety and Quality.</article-title>
            <source>Molecules</source>
            <year>2019</year>
            <month>Apr</month>
            <day>12</day>
            <volume>24</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">31013685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rainer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Stifter</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Luksch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Menapace</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the effect of Viscoat and DuoVisc on postoperative intraocular pressure after small-incision cataract surgery.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>253</fpage>
            <page-range>253-7</page-range>
            <pub-id pub-id-type="pmid">18242449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>S&#x000f6;derlind</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Virid&#x000e9;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schug</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Abrahamsson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Knopke</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tajarobi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Blume</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ansch&#x000fc;tz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Welinder</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nagel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abrahms&#x000e9;n-Alami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Weitschies</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>The influence of hydroxypropyl methylcellulose (HPMC) molecular weight, concentration and effect of food on in vivo erosion behavior of HPMC matrix tablets.</article-title>
            <source>J Control Release</source>
            <year>2014</year>
            <month>Aug</month>
            <day>10</day>
            <volume>187</volume>
            <fpage>50</fpage>
            <page-range>50-8</page-range>
            <pub-id pub-id-type="pmid">24818771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tasaka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Uda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hiramatsu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawasaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ohashi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of a new method of irrigation and aspiration for removal of ophthalmic viscoelastic device during cataract surgery in a porcine model.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2014</year>
            <month>Nov</month>
            <day>07</day>
            <volume>14</volume>
            <fpage>129</fpage>
            <pub-id pub-id-type="pmid">25376934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sim</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Amjadi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhardwaj</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dubey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>IC</given-names>
              </name>
            </person-group>
            <article-title>Assessment of adequate removal of ophthalmic viscoelastic device with irrigation/aspiration by quantifying intraocular lens 'Judders'.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>450</fpage>
            <page-range>450-4</page-range>
            <pub-id pub-id-type="pmid">23078284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mastropasqua</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carpineto</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ciancaglini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Falconio</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Intraocular pressure changes after phacoemulsification and foldable silicone lens implantation using Healon GV.</article-title>
            <source>Ophthalmologica</source>
            <year>1998</year>
            <volume>212</volume>
            <issue>5</issue>
            <fpage>318</fpage>
            <page-range>318-21</page-range>
            <pub-id pub-id-type="pmid">9693288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>V&#x000e9;lez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vel&#x000e1;squez</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Rojas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Montoya</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zuluaga</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Balparda</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Capsular block syndrome: a case report and literature review.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2014</year>
            <volume>8</volume>
            <fpage>1507</fpage>
            <page-range>1507-13</page-range>
            <pub-id pub-id-type="pmid">25152612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joshi</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Naik</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Intraoperative Evaluation of Phacoemulsification Cataract Surgery with and without the Use of Ophthalmic Viscosurgical Devices.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2020</year>
            <season>Jan-Mar</season>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-52</page-range>
            <pub-id pub-id-type="pmid">32549724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Chuck</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Toxic anterior segment syndrome-an updated review.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2018</year>
            <month>Oct</month>
            <day>25</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>276</fpage>
            <pub-id pub-id-type="pmid">30359246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brint</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>McCarty</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Disbrow</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Defaller</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Clinical comparison of Provisc and Healon in cataract surgery.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>543</fpage>
            <page-range>543-7</page-range>
            <pub-id pub-id-type="pmid">7473117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahimi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Azimi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hosseinzadeh</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Intraocular Lens Calcification: Clinico-pathological Report of Two Cases and Literature Review.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2018</year>
            <season>Apr-Jun</season>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-199</page-range>
            <pub-id pub-id-type="pmid">29719650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Binder</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Deg</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Kohl</surname>
                <given-names>FS</given-names>
              </name>
            </person-group>
            <article-title>Calcific band keratopathy after intraocular chondroitin sulfate.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1987</year>
            <month>Sep</month>
            <volume>105</volume>
            <issue>9</issue>
            <fpage>1243</fpage>
            <page-range>1243-7</page-range>
            <pub-id pub-id-type="pmid">3307722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goomer</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Maris</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Amiel</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Native hyaluronan produces less hypersensitivity than cross-linked hyaluronan.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>2005</year>
            <month>May</month>
            <issue>434</issue>
            <fpage>239</fpage>
            <page-range>239-45</page-range>
            <pub-id pub-id-type="pmid">15864059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arshinoff</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Dispersive-cohesive viscoelastic soft shell technique.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-73</page-range>
            <pub-id pub-id-type="pmid">9951659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arshinoff</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Using BSS with viscoadaptives in the ultimate soft-shell technique.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>9</issue>
            <fpage>1509</fpage>
            <page-range>1509-14</page-range>
            <pub-id pub-id-type="pmid">12231302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-142774.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arshinoff</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Norman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Tri-soft shell technique.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>8</issue>
            <fpage>1196</fpage>
            <page-range>1196-203</page-range>
            <pub-id pub-id-type="pmid">23889867</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
